SanBio Company Limited (OTCMKTS:SNBIF) Sees Significant Decrease in Short Interest

SanBio Company Limited (OTCMKTS:SNBIF) was the recipient of a large drop in short interest in the month of August. As of August 15th, there was short interest totalling 776,900 shares, a drop of 26.1% from the July 31st total of 1,050,700 shares. Based on an average daily volume of 0 shares, the short-interest ratio is currently ∞ days.

SanBio Price Performance

OTCMKTS:SNBIF opened at C$3.85 on Friday. SanBio has a fifty-two week low of C$3.80 and a fifty-two week high of C$4.25. The company has a 50 day moving average price of C$3.85 and a 200 day moving average price of C$3.84.

SanBio Company Profile

SanBio Company Limited develops, produces, and sells regenerative cell medicines for the central nervous system. The company develops SB623 that has completed a phase 2 clinical trial to treat traumatic brain injury in the United States and Japan. Its research pipeline products also comprise SB623 for ischemic and hemorrhagic strokes, age-related macular degeneration, retinitis pigments, Parkinson's disease, spinal cord injury, and Alzheimer's disease; SB618 for peripheral nerve damage; SB308 for muscular dystrophy disease; MSC1 for cancer; and MSC2 for inflammatory disease and optic neuritis.